2seventy bio, Inc.·4

Jun 15, 5:00 PM ET

Wei Lin 4

4 · 2seventy bio, Inc. · Filed Jun 15, 2023

Insider Transaction Report

Form 4
Period: 2023-06-13
Wei Lin
Director
Transactions
  • Award

    Common Stock

    2023-06-13+4,20020,800 total
  • Award

    Stock Option (right to buy)

    2023-06-13+8,4508,450 total
    Exercise: $11.81Exp: 2033-06-13Common Stock (8,450 underlying)
Footnotes (2)
  • [F1]These restricted stock units vest 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
  • [F2]This option vests 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.

Documents

3 files